OSR Health, Inc. (OTCPK: OSRH)
Health Care · Biotechnology · US
$0.22
+9.35% today · -70.1% 1Y
OSR Health, Inc. (OTCPK: OSRH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.72M and employs 22 people.
Over the last twelve months the share price has lost 70.1%, trading between 0.08 and 0.91.
Tweenvest scores OSR Health, Inc. across four factors: quality 54/100, value 67/100. Its strongest factor is value.
OSRH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.72M
- Revenue (TTM)
- $1.81M
- P/E
- —
- EPS
- -0.38
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- $0.91
- 52-week low
- $0.08
- Avg volume (3M)
- —
- Shares outstanding
- 35.12M
- Employees
- 22
- Next earnings
- —
About OSR Health, Inc.
OSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) – essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other comparable strategic transaction with one or more established businesses. The company was incorporated on February 25, 2020, and maintains its principal office in Bellevue, Washington.
- ISIN
- US68840D1028
- Founded
- 2020
- Listed since
- Mar 21, 2023
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AdAlta LimitedASX: 1AD | $7.99M | AU$0.00 | +16.67% |
| Longeveron Inc.NasdaqCM: LGVN | $7.94M | $2.49 | -66.03% |
| XTL Biopharmaceuticals Ltd.TASE: XTLB | $7.87M | ₪0.02 | -5.26% |
| Skye Bioscience, Inc.NasdaqCM: SKYE | $7.81M | $1.77 | -13.48% |
| Imunon, Inc.NasdaqCM: IMNN | $7.63M | $1.36 | -7.48% |
| Spago Nanomedical AB (publ)OM: SPAGO | $7.58M | Skr0.09 | -14.52% |
| Acurx Pharmaceuticals, Inc.NasdaqCM: ACXP | $7.33M | $1.39 | 0.00% |
| MOA Life Plus Co. Ltd.KOSDAQ: A142760 | $7.25M | ₩478.00 | -3.04% |
Figures last refreshed Sep 20, 2026.